DuoTEN Embolisatieagent voor aambeienbehandeling

DuoTEN Embolisatieagent voor aambeienbehandeling

Een gespecialiseerd embolisatiemiddel geformuleerd om te richten op en de bloedstroom verminderen naar aambeienvatenen bevordert effectieve symptoomverlichting en genezing in een minimaal invasieve manier.

Informatie

DuoTEN is een innovatief en betrouwbare embolization agent formulated to treat a wide range of slagader en venous hemorrhoids, including pelvic, vulvar, gastrointestinal, colonen anal lesions. By combining DuoTEN met dextrose in a 1:1 or 1:2 ratio (depending on procedural preference), clinicians achieve nauwkeurig, minimally invasive occlusion of hemorrhoidal vessels—leading to rapid symptom relief and verbeterde patient outcomes. Its easy-to-use design, cost effectivenessen comfortable application make DuoTEN a trusted choice for healthcare professionals working in various endovascular or proctological settings.

Key Features and Technology

DuoTEN + Dextrose (1:1 or 1:2 Mix)
  • Safe Embolization: The mixture establishes a betrouwbare occlusive effect on hemorrhoidal vasculature while maintaining control over flow rate.
  • Adjustable Consistency: Depending on the proportion used, physicians can modulate viscosity for better vessel targeting or extended dwell time.
  • Wide Applicability: Addresses an array of hemorrhoid etiologies—pelvic, vulvar, gastrointestinal, colonen anal manifestations.
  • Targeted Vascular Shutdown: Localized embolization reduces abnormal blood flow and alleviates patient discomfort quickly.
  • Straightforward Mixing: Simple ratio-based combination with dextrose ensures minimal preparation time and consistent results.
  • Minimal Instrumentation: Employs standard endovascular or proctological delivery systems, streamlining procedure steps and lowering resource overhead.
  • Safe Embolization: The mixture establishes a betrouwbare occlusive effect on hemorrhoidal vasculature while maintaining control over flow rate.
  • Adjustable Consistency: Depending on the proportion used, physicians can modulate viscosity for better vessel targeting or extended dwell time.
  • Wide Applicability: Addresses an array of hemorrhoid etiologies—pelvic, vulvar, gastrointestinal, colonen anal manifestations.
  • Targeted Vascular Shutdown: Localized embolization reduces abnormal blood flow and alleviates patient discomfort quickly.
  • Straightforward Mixing: Simple ratio-based combination with dextrose ensures minimal preparation time and consistent results.
  • Minimal Instrumentation: Employs standard endovascular or proctological delivery systems, streamlining procedure steps and lowering resource overhead.

Clinical Advantages & Indications

Minimally Invasive Hemorrhoid Management
  • Decreased Surgical Burden: May reduce or avoid the need for more extensive surgical procedures, such as hemorrhoidectomy.
  • Rapid Symptom Relief: Embolization curtails bleeding and discomfort, enabling a quick return to normal activities.
  • Localized Occlusion: Embolization is restricted to the target vessels, minimizing systemic impact or risk of collateral damage.
  • Gentle Tissue Interaction: Formulation with dextrose fosters a biologically compatible environment, translating to less postoperative discomfort.
  • Fewer Resources: By offering a straightforward mixing protocol and single injection, clinicians reduce procedure time and consumables.
  • Lower Recurrence: Effective occlusion and reduced complication rates can drive down long-term management costs.
  • Multiple Hemorrhoid Types: Employed for varied hemorrhoidal anatomies (internal, external, vulvar, etc.), ensuring broad clinical utility.
  • Adapted to Routine Practice: Integrates seamlessly with existing endovascular or proctology-based delivery equipment.
  • Decreased Surgical Burden: May reduce or avoid the need for more extensive surgical procedures, such as hemorrhoidectomy.
  • Rapid Symptom Relief: Embolization curtails bleeding and discomfort, enabling a quick return to normal activities.
  • Localized Occlusion: Embolization is restricted to the target vessels, minimizing systemic impact or risk of collateral damage.
  • Gentle Tissue Interaction: Formulation with dextrose fosters a biologically compatible environment, translating to less postoperative discomfort.
  • Fewer Resources: By offering a straightforward mixing protocol and single injection, clinicians reduce procedure time and consumables.
  • Lower Recurrence: Effective occlusion and reduced complication rates can drive down long-term management costs.
  • Multiple Hemorrhoid Types: Employed for varied hemorrhoidal anatomies (internal, external, vulvar, etc.), ensuring broad clinical utility.
  • Adapted to Routine Practice: Integrates seamlessly with existing endovascular or proctology-based delivery equipment.

Gerelateerde producten